Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of antibody-based solutions for infectious diseases.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Adagio Therapeutics, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Adagio Therapeutics, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.